An increasing number of studies have described the role of vimentin in lymphatic invasion and lymph node metastasis of oral, esophageal, gastric, prostate, and colorectal squamous cell carcinomas. This evidence concerns the gene VIM and metastatic malignant neoplasm in the lymph nodes.